Correlation between TNF‐<i>α</i> ‐308 and +489 Gene Polymorphism and Acute Exacerbation of Chronic Obstructive Pulmonary Diseases
Suyun Yu, Min Xue, Zhijun Yan, Bin Song, Hai-Ping Hong, Xiwen Gao
Abstract
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is becoming a common respiratory disease, leading to increased morbidity and mortality worldwide. Tumor necrosis factor‐alpha (TNF‐ α ) is a powerful proinflammatory cytokine involved in the pathogenesis of AECOPD. Therefore, we proposed a close correlation between the TNF‐ α polymorphism [‐308G/A (rs1800629), +489G/A (rs1800610)] and the disease progress of patients with AECOPD. Comparison of the TNF‐ α genotypes between the 198 AECOPD diagnosed patients groups and 195 healthy peoples suggested their significant differences of the three genotypes (AA, GA, GG) distribution for TNF‐ α ‐308 ( P < 0.05), but no differences of that for TNF‐ α +489. We found that patients with TNF‐ α ‐308 GA/AA genotypes showed smaller adjacent arterial diameter, thicker bronchial wall, higher bronchial artery ratio, higher bronchial wall grading, and higher frequency of acute exacerbations than those with TNF‐ α ‐308 GG genotype. Patients with TNF‐ α +489 GA/AA genotypes showed the same AECOPD properties as patients with TNF‐ α ‐308 except for the high frequency of acute exacerbations. Further experiment showed that the TNF‐ α ‐308 and+489 gene polymorphisms could affect the expression level of TNF‐ α in macrophages, suggesting the involvement of the macrophage population in disease regulation of AECOPD patients with TNF‐ α ‐308G/A and+489G/A genotype heterogeneity. In conclusion, the TNF‐ α ‐308 G/A genotype was related to AECOPD susceptibility and progress, while the TNF‐ α +489G/A genotype was related to AECOPD progress, but not AECOPD susceptibility.